Wall Street analysts did not think the data showed enough differentiation.

CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...

TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...

President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...

Amgen's phase 2 data disappointed, but its obesity pipeline still holds potential. See why AMGN stock is appealing even ...

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...

Dr. Caroline Apovian says you can still enjoy the holidays and festive meals while you're taking GLP-1 medications if you ...

Does Ozempic cause hair loss? I asked a board-certified OB/GYN about why some folks on GLP-1 medications like Ozempic, Wegovy ...